Prescription-drug prices

New England Journal of Medicine

Volumn 351, Issue 14, 2004, Pages 1375-1377

  Frank, Richard G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BUDGET; COST CONTROL; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; ECONOMIC ASPECT; GOVERNMENT; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; MEDICARE; MONEY; PRESCRIPTION; PRIORITY JOURNAL; PURCHASING; RELIABILITY; REVIEW; UNITED STATES; ARTICLE; COMMERCIAL PHENOMENA; DRUG CONTROL; ECONOMICS; EUROPE; FEE; GOVERNMENT REGULATION; HEALTH INSURANCE; LEGAL ASPECT; MEDICAL RESEARCH; POLITICS;

BIOMEDICAL RESEARCH; COMMERCE; DRUG AND NARCOTIC CONTROL; DRUG COSTS; DRUG INDUSTRY; EUROPE; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICARE; POLITICS; PRESCRIPTION FEES; UNITED STATES;

EID: 4644289636     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048158     Document Type: Review

References (5)

1. Levit K, Smith C, Cowan C, Sensenig A, Catlin A. Health spending rebound continues in 2002. Health Aff (Millwood) 2004;23(1):147-59.
2. Baker C. Would prescription drug reimportation reduce U.S. drug spending? Economic and budget issue brief. Washington, D.C.: Congressional Budget Office, April 29, 2004.
3. Badger D. Ask the White House. February 4, 2004. (Accessed September 10, 2004, at http://www.whitehouse.gov/ask/20040204. html.)
4. President Bush discusses quality, affordable health care: remarks by the President on access to health care. January 28, 2004. (Accessed September 10, 2004, at http://www.whitehouse. gov/news/releases/2004/01/20040128-2.html.)
5. Republican National Committee. Republican party platform. (Accessed September 10, 2004, at http://www.gop.com/about/partyplatform.)